Related references
Note: Only part of the references are listed.Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma
Bo Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network
Yu-Kun Xia et al.
PROTEIN & CELL (2021)
COMPASS and SWI/SNF complexes in development and disease
Bercin K. Cenik et al.
NATURE REVIEWS GENETICS (2021)
A histone H3.3K36M mutation in mice causes an imbalance of histone modifications and defects in chondrocyte differentiation
Shusaku Abe et al.
EPIGENETICS (2021)
PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway
Yujiao Hu et al.
EXPERIMENTAL CELL RESEARCH (2021)
Competition between PRC2.1 and 2.2 subcomplexes regulates PRC2 chromatin occupancy in human stem cells
Daniel T. Youmans et al.
MOLECULAR CELL (2021)
CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway
Miaomiao Zeng et al.
MOLECULAR MEDICINE REPORTS (2021)
NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain
Sanxiong Liu et al.
MOLECULAR CELL (2021)
H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions
Yichao Cai et al.
NATURE COMMUNICATIONS (2021)
YAF2 exerts anti-apoptotic effect in human tumor cells in a FANK1-and phosphorylation-dependent manner
Shiqiang Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Understanding 3D genome organization by multidisciplinary methods
Ivana Jerkovic et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
The roles of Polycomb repressive complexes in mammalian development and cancer
Andrea Piunti et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
A conserved BAH module within mammalian BAHD1 connects H3K27me3 to Polycomb gene silencing
Huitao Fan et al.
NUCLEIC ACIDS RESEARCH (2021)
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL
Guillaume P. Andrieu et al.
BLOOD (2021)
BAP1 enhances Polycomb repression by counteracting widespread H2AK119ub1 deposition and chromatin condensation
Eric Conway et al.
MOLECULAR CELL (2021)
PCGF1 promotes epigenetic activation of stemness markers and colorectal cancer stem cell enrichment
Guangyu Ji et al.
CELL DEATH & DISEASE (2021)
Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness
Haritha Mathsyaraja et al.
ELIFE (2021)
Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types
Maksim Erokhin et al.
CANCERS (2021)
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer
Sen Zhu et al.
ONCOGENE (2020)
beta-TRCP-mediated AEBP2 ubiquitination and destruction controls cisplatin resistance in ovarian cancer
Qin Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Principles and mechanisms of non-genetic resistance in cancer
Charles C. Bell et al.
BRITISH JOURNAL OF CANCER (2020)
Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer
Sharanya Sivanand et al.
CANCER CELL (2020)
A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis
Kun Liao et al.
CANCER RESEARCH (2020)
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells
Jakob Hofvander et al.
MODERN PATHOLOGY (2020)
A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin
Siming Chen et al.
MOLECULAR CELL (2020)
Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression
Simone Tamburri et al.
MOLECULAR CELL (2020)
PRC1 Catalytic Activity Is Central to Polycomb System Function
Neil P. Blackledge et al.
MOLECULAR CELL (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Widespread activation of developmental gene expression characterized by PRC1-dependent chromatin looping
V Loubiere et al.
SCIENCE ADVANCES (2020)
CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma
Nan Jiang et al.
EBIOMEDICINE (2020)
Activity of PRC1 and Histone H2AK119 Monoubiquitination: Revising Popular Misconceptions
Idan Cohen et al.
BIOESSAYS (2020)
PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells
Payal Jain et al.
ELIFE (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells
Fei Wang et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor
Tengrui Zhang et al.
CLINICAL EPIGENETICS (2020)
Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a
Tengteng Yu et al.
MOLECULAR CANCER RESEARCH (2020)
Germline Elongator mutations in Sonic Hedgehog medulloblastoma
Sebastian M. Waszak et al.
NATURE (2020)
Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation
Delphine Douillet et al.
NATURE GENETICS (2020)
The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
Maryam Althobiti et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
Huairui Yuan et al.
CANCER CELL (2020)
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse
Lingfei Jia et al.
CELL STEM CELL (2020)
Estrogen induces dynamic ER alpha( )and RING1B recruitment to control gene and enhancer activities in luminal breast cancer
Yusheng Zhang et al.
SCIENCE ADVANCES (2020)
The polycomb group protein PCGF6 mediates germline gene silencing by recruiting histone-modifying proteins to target gene promoters
Mengjie Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis
Zhongwei Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis
Zhongwei Li et al.
CELL DEATH AND DIFFERENTIATION (2020)
Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation
Lena M. Kutscher et al.
GENES & DEVELOPMENT (2020)
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal Gounder et al.
LANCET ONCOLOGY (2020)
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
Franck Morschhauser et al.
LANCET ONCOLOGY (2020)
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2
Siddhant U. Jain et al.
MOLECULAR CELL (2020)
Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition
Hye-Jung Kim et al.
TRENDS IN IMMUNOLOGY (2020)
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
Sima Khazaei et al.
CANCER DISCOVERY (2020)
CBX6 Promotes HCC Metastasis Via Transcription Factors Snail/Zeb1-Mediated EMT Mechanism
Jiamu Wang et al.
ONCOTARGETS AND THERAPY (2020)
H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation
Ashot S. Harutyunyan et al.
CELL REPORTS (2020)
BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis
Huitao Fan et al.
NATURE GENETICS (2020)
Functions of Polycomb Proteins on Active Targets
Natalia Giner-Laguarda et al.
EPIGENOMES (2020)
Cell Fate and Developmental Regulation Dynamics by Polycomb Proteins and 3D Genome Architecture
Vincent Loubiere et al.
BIOESSAYS (2019)
Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer
Swathi Ramakrishnan et al.
CELL DEATH AND DIFFERENTIATION (2019)
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
Tian Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The expanding landscape of 'oncohistone' mutations in human cancers
Benjamin A. Nacev et al.
NATURE (2019)
EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains
Maria C. Donaldson-Collier et al.
NATURE GENETICS (2019)
EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma
Jens-Martin Huebner et al.
NEURO-ONCOLOGY (2019)
High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway
Qingke Duan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Functional Landscape of PCGF Proteins Reveals Both RING1A/B-Dependent-and RING1A/B-Independent-Specific Activities
Andrea Scelfo et al.
MOLECULAR CELL (2019)
Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer
Ho Lam Chan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Principles of genome folding into topologically associating domains
Quentin Szabo et al.
SCIENCE ADVANCES (2019)
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su et al.
CANCER CELL (2019)
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
Charles C. Bell et al.
NATURE COMMUNICATIONS (2019)
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
Zhimin Gu et al.
CANCER DISCOVERY (2019)
Discovery of selective activators of PRC2 mutant EED-I363M
Junghyun L. Suh et al.
SCIENTIFIC REPORTS (2019)
CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism
Andrea Piunti et al.
SCIENCE ADVANCES (2019)
Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors
Ratnakar Singh et al.
CANCERS (2019)
MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma
Boheng Li et al.
BLOOD (2019)
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
Michael Broux et al.
BLOOD (2019)
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation
Zhihong Ren et al.
BLOOD (2019)
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
Marian L. Burr et al.
CANCER CELL (2019)
Redistribution of EZH2 promotes malignant phenotypes by rewiring developmental programmes
Thomas Mortimer et al.
EMBO REPORTS (2019)
Non-core Subunits of the PRC2 Complex Are Collectively Required for Its Target-Site Specificity
Jonas Westergaard Hojfeldt et al.
MOLECULAR CELL (2019)
PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation
Evan Healy et al.
MOLECULAR CELL (2019)
BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers
Jeffim N. Kuznetsov et al.
SCIENCE ADVANCES (2019)
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells
Roberta Ragazzini et al.
NATURE COMMUNICATIONS (2019)
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
Lei Nie et al.
NATURE COMMUNICATIONS (2019)
Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy
Alison Hirukawa et al.
CELL REPORTS (2019)
Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis
Yi Zeng et al.
CELL REPORTS (2019)
Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
Qipeng Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway
Ai-Hua Tong et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2019)
BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation
Antoine Campagne et al.
NATURE COMMUNICATIONS (2019)
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer
Houliang Deng et al.
SCIENTIFIC REPORTS (2019)
KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis
Yusuke Isshiki et al.
BLOOD ADVANCES (2019)
The Down-Regulation of SUZ12 Accelerates the Migration and Invasion of Liver Cancer Cells via Activating ERK1/2 Pathway
Cailin Xue et al.
JOURNAL OF CANCER (2019)
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
H. Courtney Hodges et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
H. Courtney Hodges et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas
Kristian W. Pajtler et al.
ACTA NEUROPATHOLOGICA (2018)
CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer
Lian-Yu Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Double sword role of EZH2 in leukemia
Sahar Safaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
PRC1 Fine-tunes Gene Repression and Activation to Safeguard Skin Development and Stem Cell Specification
Idan Cohen et al.
CELL STEM CELL (2018)
Branched-chain amino acid metabolism in cancer
Elitsa A. Ananieva et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2018)
The contributions of cancer cell metabolism to metastasis
Gloria Pascual et al.
DISEASE MODELS & MECHANISMS (2018)
Long non-coding RNA and Polycomb: an intricate partnership in cancer biology
Cyrinne Achour et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma
HuaYong Zhang et al.
GENE (2018)
Multiple roles of Ring 1 and YY1 binding protein in physiology and disease
Shaohua Zhan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
Yaping Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Antoine Italiano et al.
LANCET ONCOLOGY (2018)
The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells
Gundula Streubel et al.
MOLECULAR CELL (2018)
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Lixin Wan et al.
MOLECULAR CELL (2018)
Polycomb-Dependent Chromatin Looping Contributes to Gene Silencing during Drosophila Development
Yuki Ogiyama et al.
MOLECULAR CELL (2018)
MTF2 recruits Polycomb Repressive Complex 2 by helical-shape-selective DNA binding
Matteo Perino et al.
NATURE GENETICS (2018)
The Key Role of Epigenetics in Human Disease Prevention and Mitigation
Andrew P. Feinberg
NEW ENGLAND JOURNAL OF MEDICINE (2018)
O-GlcNAcylation regulates the stability and enzymatic activity of the histone methyltransferase EZH2
Pei-Wen Lo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma
Yu-Feng Yang et al.
TRANSLATIONAL ONCOLOGY (2018)
BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1
Sen Zhu et al.
NATURE COMMUNICATIONS (2018)
p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis
Talha Anwar et al.
NATURE COMMUNICATIONS (2018)
Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing
Qianying Zhao et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
David Wang et al.
CELL REPORTS (2018)
H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers
Dong Fang et al.
ELIFE (2018)
PCL2 regulates p53 stability and functions as a tumor suppressor in breast cancer
Yiran Liang et al.
SCIENCE BULLETIN (2018)
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy
Sangeeta Goswami et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Ezh2 loss propagates hypermethylation at T cell differentiation-regulating genes to promote leukemic transformation
Changshan Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms
Ho Lam Chan et al.
NATURE COMMUNICATIONS (2018)
Loss of PRC1 induces higher-order opening of Hox loci independently of transcription during Drosophila embryogenesis
Thierry Cheutin et al.
NATURE COMMUNICATIONS (2018)
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells
Hamza Celik et al.
CANCER CELL (2018)
PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis
Qing Deng et al.
CELL DEATH & DISEASE (2018)
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
Jung Kim et al.
CELL REPORTS (2018)
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
Lindsay J. Wheeler et al.
ONCOGENESIS (2018)
CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer
Shih-Chieh Chang et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma
Chris Zhiyi Zhang et al.
CANCER RESEARCH (2018)
Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states
Cigall Kadoch et al.
NATURE GENETICS (2017)
Polycomb Repressor Complex 2 in Genomic Instability and Cancer
Zoe Veneti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion
Xin Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies
Tomoyuki Tanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Polycomb Repressive Complex 2 Methylates Elongin A to Regulate Transcription
M. Behfar Ardehali et al.
MOLECULAR CELL (2017)
Polycomb Repressive Complex 1 Generates Discrete Compacted Domains that Change during Differentiation
Sharmistha Kundu et al.
MOLECULAR CELL (2017)
Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway
Jian Cao et al.
MOLECULAR MEDICINE REPORTS (2017)
Polycomb-like proteins link the PRC2 complex to CpG islands
Haojie Li et al.
NATURE (2017)
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas
Simon Papillon-Cavanagh et al.
NATURE GENETICS (2017)
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
Alvin P. Makohon-Moore et al.
NATURE GENETICS (2017)
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
Oliver G. McDonald et al.
NATURE GENETICS (2017)
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti et al.
NATURE MEDICINE (2017)
O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer
Y. Li et al.
ONCOGENE (2017)
NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma
P-S Hu et al.
ONCOGENE (2017)
Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma
Elisa Oricchio et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Depletion of polycomb repressive complex 2 core component EED impairs fetal hematopoiesis
Wenhua Yu et al.
CELL DEATH & DISEASE (2017)
CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
Hao Zheng et al.
Oncotarget (2017)
CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle
Yao Fan et al.
ONCOTARGET (2017)
Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation
Mathangi Srinivasan et al.
ONCOTARGET (2017)
Prognostic values of distinct CBX family members in breast cancer
Yuan-Ke Liang et al.
ONCOTARGET (2017)
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
Daniel Zingg et al.
CELL REPORTS (2017)
Polycomb repressive complex 1 modifies transcription of active genes
Michelle Pherson et al.
SCIENCE ADVANCES (2017)
Multiscale 3D Genome Rewiring during Mouse Neural Development
Boyan Bonev et al.
CELL (2017)
Genome Regulation by Polycomb and Trithorax: 70 Years and Counting
Bernd Schuettengruber et al.
CELL (2017)
Tumor suppressor RYBP harbors three nuclear localization signals and its cytoplasm-located mutant exerts more potent anti-cancer activities than corresponding wild type
Kuan Tan et al.
CELLULAR SIGNALLING (2017)
EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway
Hao Zhang et al.
TUMOR BIOLOGY (2016)
EZH2 in normal hematopoiesis and hematological malignancies
Laurie Herviou et al.
ONCOTARGET (2016)
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
Junli Yan et al.
BLOOD (2016)
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis
Wendy Beguelin et al.
CANCER CELL (2016)
CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma
Xin Wang et al.
CANCER RESEARCH (2016)
BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer
Nitu Bansal et al.
CLINICAL CANCER RESEARCH (2016)
Emerging roles for Polycomb proteins in cancer
Diego Pasini et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies
Emi Takamatsu-Ichihara et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
RING1 and YY1 binding protein suppresses breast cancer growth and metastasis
Hongyan Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas
Rishi G. Vaswani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
EPOP Interacts with Elongin BC and USP7 to Modulate the Chromatin Landscape
Robert Liefke et al.
MOLECULAR CELL (2016)
Coordinate redeployment of PRC1 proteins suppresses tumor formation during Drosophila development
Vincent Loubiere et al.
NATURE GENETICS (2016)
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation
George P. Souroullas et al.
NATURE MEDICINE (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Polycomb inhibits histone acetylation by CBP by binding directly to its catalytic domain
Feng Tie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression
Takeshi Ueda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
Chao Lu et al.
SCIENCE (2016)
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas
Dong Fang et al.
SCIENCE (2016)
Jarid2 binds mono-ubiquitylated H2A lysine 119 to mediate crosstalk between Polycomb complexes PRC1 and PRC2
Sarah Cooper et al.
NATURE COMMUNICATIONS (2016)
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
Hamid Nikbakht et al.
NATURE COMMUNICATIONS (2016)
Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2
Neil Justin et al.
NATURE COMMUNICATIONS (2016)
Chromatin topology is coupled to Polycomb group protein subnuclear organization
Ajazul H. Wani et al.
NATURE COMMUNICATIONS (2016)
Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study
Min-Cong Wang et al.
Oncotarget (2016)
EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
Bo Pang et al.
ONCOTARGET (2016)
Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia
Stefan Nagel et al.
ONCOTARGET (2016)
JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling
Xiong Lei et al.
ONCOTARGET (2016)
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers
How-Wen Ko et al.
ONCOTARGET (2016)
The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia
Nikos Papakonstantinou et al.
ONCOTARGET (2016)
Cbx8 Acts Non-canonically with Wdr5 to Promote Mammary Tumorigenesis
Chi-Yeh Chung et al.
CELL REPORTS (2016)
Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis
Vincent van den Boom et al.
CELL REPORTS (2016)
The BAH domain of BAHD1 is a histone H3K27me3 reader
Dan Zhao et al.
PROTEIN & CELL (2016)
Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers
Ji-Hyun Lee et al.
CELL DISCOVERY (2016)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells
Tsang-Pai Liu et al.
ANTI-CANCER DRUGS (2015)
Polycomb repressive complex 2 component Suz12 is required for hematopoietic stem cell function and lymphopoiesis
Stanley C. W. Lee et al.
BLOOD (2015)
Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner
Makiko Mochizuki-Kashio et al.
BLOOD (2015)
Polycomb Regulates Mesoderm Cell Fate-Specification in Embryonic Stem Cells through Activation and Repression Mechanisms
Lluis Morey et al.
CELL STEM CELL (2015)
Small-Molecule Modulators of Methyl-Lysine Binding for the CBX7 Chromodomain
Chunyan Ren et al.
CHEMISTRY & BIOLOGY (2015)
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2
Stephen G. Dann et al.
EMBO JOURNAL (2015)
Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis
Michel Wassef et al.
GENES & DEVELOPMENT (2015)
Recruiting polycomb to chromatin
Ha van Kruijsbergen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma
Jiro Kikuchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches
V. D'Angelo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Polycomb repressive complex PRC1 spatially constrains the mouse embryonic stem cell genome
Stefan Schoenfelder et al.
NATURE GENETICS (2015)
Loss of BAP1 function leads to EZH2-dependent transformation
Lindsay M. LaFave et al.
NATURE MEDICINE (2015)
PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression
Junhu Wan et al.
NUCLEIC ACIDS RESEARCH (2015)
MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma
Hui Xu et al.
ONCOLOGY REPORTS (2015)
Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma
H-K Jiao et al.
CELL DEATH & DISEASE (2015)
BMI-1, a promising therapeutic target for human cancer (Review)
Min-Cong Wang et al.
ONCOLOGY LETTERS (2015)
Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex
Anand Balasubramani et al.
NATURE COMMUNICATIONS (2015)
Dual Roles of RNF2 in Melanoma Progression
Kunal Rai et al.
CANCER DISCOVERY (2015)
MEL-18, a tumor suppressor for aggressive breast cancer
Jeong-Yeon Lee et al.
ONCOTARGET (2015)
Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer
Yan-Long Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation
A. A. Sahasrabuddhe et al.
ONCOGENE (2015)
HP1 beta Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
Young-Ho Lee et al.
PLOS ONE (2015)
Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications
Huali Wang et al.
BMC CANCER (2014)
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
Roberta Ciarapica et al.
BMC CANCER (2014)
Cbx4 Governs HIF-1α to Potentiate Angiogenesis of Hepatocellular Carcinoma by Its SUMO E3 Ligase Activity
Jie Li et al.
CANCER CELL (2014)
NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
Filippos Kottakis et al.
CANCER RESEARCH (2014)
Variant PRC1 Complex-Dependent H2A Ubiquitylation Drives PRC2 Recruitment and Polycomb Domain Formation
Neil P. Blackledge et al.
CELL (2014)
Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner
Huafeng Xie et al.
CELL STEM CELL (2014)
Trithorax monomethylates histone H3K4 and interacts directly with CBP to promote H3K27 acetylation and antagonize Polycomb silencing
Feng Tie et al.
DEVELOPMENT (2014)
Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma
Barbara Dewaele et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Histone Methyltransferase EZH2 Is Transcriptionally Induced by Estradiol as Well as Estrogenic Endocrine Disruptors Bisphenol-A and Diethylstilbestrol
Arunoday Bhan et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins
Rong-gang Ma et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Gene Silencing Triggers Polycomb Repressive Complex 2 Recruitment to CpG Islands Genome Wide
Eva Madi Riising et al.
MOLECULAR CELL (2014)
Polycomb-Dependent H3K27me1 and H3K27me2 Regulate Active Transcription and Enhancer Fidelity
Karin J. Ferrari et al.
MOLECULAR CELL (2014)
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S. C. Mack et al.
NATURE (2014)
An AUTS2-Polycomb complex activates gene expression in the CNS
Zhonghua Gao et al.
NATURE (2014)
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2014)
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
Z. S. Walters et al.
ONCOGENE (2014)
Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer
J-Y Lee et al.
ONCOGENE (2014)
O-GlcNAcylation regulates EZH2 protein stability and function
Chi-Shuen Chu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis
Shan-Shan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling
Hans-Martin Herz et al.
SCIENCE (2014)
Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion
Min Zhou et al.
ONCOLOGY LETTERS (2014)
The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells
Almudena Bosch et al.
ONCOTARGET (2014)
Regulation and Role of EZH2 in Cancer
Hirohito Yamaguchi et al.
CANCER RESEARCH AND TREATMENT (2014)
EZH2-Mediated Inactivation of IFN-γ-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer
Zhen Ning Wee et al.
CELL REPORTS (2014)
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
Junli Yan et al.
BLOOD (2013)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1
Sang Hyup Lee et al.
CANCER LETTERS (2013)
Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
Yung-Luen Yu et al.
EMBO MOLECULAR MEDICINE (2013)
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Kui-Ming Chan et al.
GENES & DEVELOPMENT (2013)
RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12)
Ioannis Panagopoulos et al.
GENES CHROMOSOMES & CANCER (2013)
BMI1, The polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma
Leila Rouhigharabaei et al.
GENES CHROMOSOMES & CANCER (2013)
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
Tomoya Muto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The Aurora B Kinase and the Polycomb Protein Ring1B Combine to Regulate Active Promoters in Quiescent Lymphocytes
Alberto Frangini et al.
MOLECULAR CELL (2013)
Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes
Jin He et al.
NATURE CELL BIOLOGY (2013)
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Sam Behjati et al.
NATURE GENETICS (2013)
Altered Expression of Polycomb Group Genes in Glioblastoma Multiforme
Gang Li et al.
PLOS ONE (2013)
A Histone Mutant Reproduces the Phenotype Caused by Loss of Histone-Modifying Factor Polycomb
Ana Raquel Pengelly et al.
SCIENCE (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
RYBP and Cbx7 Define Specific Biological Functions of Polycomb Complexes in Mouse Embryonic Stem Cells
Lluis Morey et al.
CELL REPORTS (2013)
Cohesin and Polycomb Proteins Functionally Interact to Control Transcription at Silenced and Active Genes
Cheri A. Schaaf et al.
PLOS GENETICS (2013)
Recurrent Rearrangement of the PHF1 Gene in Ossifying Fibromyxoid Tumors
Samuel Gebre-Medhin et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
PHF19 and Akt control the switch between proliferative and invasive states in melanoma
Stephanie Ghislin et al.
CELL CYCLE (2012)
Polycomb Associates Genome-wide with a Specific RNA Polymerase II Variant, and Regulates Metabolic Genes in ESCs
Emily Brookes et al.
CELL STEM CELL (2012)
Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway
Hee-Young Won et al.
FASEB JOURNAL (2012)
Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk
Arie B. Brinkman et al.
GENOME RESEARCH (2012)
SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK
Hua Li et al.
MOLECULAR CANCER RESEARCH (2012)
PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family Complexes
Zhonghua Gao et al.
MOLECULAR CELL (2012)
Direct Recruitment of Polycomb Repressive Complex 1 to Chromatin by Core Binding Transcription Factors
Ming Yu et al.
MOLECULAR CELL (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos et al.
NATURE MEDICINE (2012)
The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells
Yong Jae Shin et al.
PLOS ONE (2012)
PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer Lymph Node Metastasis Compared to Primary Tumor and Correlates with Tumor Proliferation In Situ
Hongxiang Yu et al.
PLOS ONE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Polycomb-Like 3 Promotes Polycomb Repressive Complex 2 Binding to CpG Islands and Embryonic Stem Cell Self-Renewal
Julie Hunkapiller et al.
PLOS GENETICS (2012)
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
Damian B. Yap et al.
BLOOD (2011)
KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia
Jin He et al.
BLOOD (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
Compaction of chromatin by diverse Polycomb group proteins requires localized regions of high charge
Daniel J. Grau et al.
GENES & DEVELOPMENT (2011)
Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation
Volkhard Seitz et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability
Susan C. Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer
Bao-Hong Guo et al.
MOLECULAR CANCER (2011)
L3MBTL2 Protein Acts in Concert with PcG Protein-Mediated Monoubiquitination of H2A to Establish a Repressive Chromatin Structure
Patrick Trojer et al.
MOLECULAR CELL (2011)
CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells
Yongkun Wei et al.
NATURE CELL BIOLOGY (2011)
Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway
J-H Park et al.
ONCOGENE (2011)
A Bacterial Protein Targets the BAHD1 Chromatin Complex to Stimulate Type III Interferon Response
Alice Lebreton et al.
SCIENCE (2011)
Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms
M. Brecqueville et al.
BLOOD CANCER JOURNAL (2011)
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer
Bethany N. Hannafon et al.
BREAST CANCER RESEARCH (2011)
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
Sha Hu et al.
CANCER BIOLOGY & THERAPY (2010)
Polycomb group molecule PHC3 regulates polycomb complex composition and prognosis of osteosarcoma
Shintaro Iwata et al.
CANCER SCIENCE (2010)
A Region of the Human HOXD Cluster that Confers Polycomb-Group Responsiveness
Caroline J. Woo et al.
CELL (2010)
Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA
Syuzo Kaneko et al.
GENES & DEVELOPMENT (2010)
Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells
Wei Li et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer
Xiao-Wei Zhang et al.
MOLECULAR CANCER (2010)
Ring1B Compacts Chromatin Structure and Represses Gene Expression Independent of Histone Ubiquitination
Ragnhild Eskeland et al.
MOLECULAR CELL (2010)
PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia
E. Coyaud et al.
LEUKEMIA RESEARCH (2010)
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Christopher J. Sneeringer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Polycomb Group Targeting through Different Binding Partners of RING1B C-Terminal Domain
Renjing Wang et al.
STRUCTURE (2010)
GC-Rich Sequence Elements Recruit PRC2 in Mammalian ES Cells
Eric M. Mendenhall et al.
PLOS GENETICS (2010)
A Vertebrate Polycomb Response Element Governs Segmentation of the Posterior Hindbrain
Angela Sing et al.
CELL (2009)
CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing
Feng Tie et al.
DEVELOPMENT (2009)
A tumor suppressor activity of Drosophila Polycomb genes mediated by JAK-STAT signaling
Anne-Kathrin Classen et al.
NATURE GENETICS (2009)
Polyhomeotic has a tumor suppressor activity mediated by repression of Notch signaling
Anne-Marie Martinez et al.
NATURE GENETICS (2009)
Human BAHD1 promotes heterochromatic gene silencing
Helene Bierne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer
Pierlorenzo Pallante et al.
CANCER RESEARCH (2008)
Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation
Takeya Nakagawa et al.
GENES & DEVELOPMENT (2008)
Histione H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation
Wenlai Zhou et al.
MOLECULAR CELL (2008)
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Manching Ku et al.
PLOS GENETICS (2008)
Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells
Julie K. Stock et al.
NATURE CELL BIOLOGY (2007)
Polycomb response elements mediate the formation of chromosome higher-order structures in the bithorax complex
Chiara Lanzuolo et al.
NATURE CELL BIOLOGY (2007)
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells
Bin Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells
Wei-Jian Guo et al.
CANCER RESEARCH (2007)
Role of the chromobox protein CBX7 in lymphomagenesis
Clare L. Scott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors
A. M. Deshpande et al.
ONCOGENE (2007)
Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins
Wei-Jian Guo et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element
Yanhua Gong et al.
NUCLEIC ACIDS RESEARCH (2006)
Variability in the expression of polycomb proteins in different normal and tumoral tissues.: A pilot study using tissue microarrays
M Sánchez-Beato et al.
MODERN PATHOLOGY (2006)
Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma
F Micci et al.
CANCER RESEARCH (2006)
Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3
TL Cha et al.
SCIENCE (2005)
CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus
D Bernard et al.
ONCOGENE (2005)
Polycomb silencing blocks transcription initiation
GI Dellino et al.
MOLECULAR CELL (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Chromatin compaction by a polycomb group protein complex
NJ Francis et al.
SCIENCE (2004)
Role of histone H2A ubiquitination in polycomb silencing
HB Wang et al.
NATURE (2004)
Structural basis for specific binding of polycomb chromodomain to histone H3 methylated at Lys 27
JR Min et al.
GENES & DEVELOPMENT (2003)
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
A Kuzmichev et al.
GENES & DEVELOPMENT (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans
SS Levine et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
S Vonlanthen et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
